These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33211137)

  • 1. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass in adult patients undergoing cardiac surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Takahashi H; Makita K; Arai H; Kijima S; Echizen H; Yasuhara M
    Eur J Clin Pharmacol; 2021 May; 77(5):735-745. PubMed ID: 33211137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of cefazolin before, during and after cardiopulmonary bypass to optimize dosing regimens for children undergoing cardiac surgery.
    De Cock PA; Mulla H; Desmet S; De Somer F; McWhinney BC; Ungerer JP; Moerman A; Commeyne S; Vande Walle J; Francois K; Van Hasselt JG; De Paepe P
    J Antimicrob Chemother; 2017 Mar; 72(3):791-800. PubMed ID: 27999040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cardiopulmonary bypass on the disposition of cefazolin in patients undergoing cardiothoracic surgery.
    Asada M; Nagata M; Mizuno T; Uchida T; Kurashima N; Takahashi H; Makita K; Arai H; Echizen H; Yasuhara M
    Pharmacol Res Perspect; 2018 Dec; 6(6):e00440. PubMed ID: 30410768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic characteristics and microbiologic appropriateness of cefazolin for perioperative antibiotic prophylaxis in elective cardiac surgery.
    Lanckohr C; Horn D; Voeller S; Hempel G; Fobker M; Welp H; Koeck R; Ellger B
    J Thorac Cardiovasc Surg; 2016 Aug; 152(2):603-10. PubMed ID: 27209020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial.
    Naik BI; Roger C; Ikeda K; Todorovic MS; Wallis SC; Lipman J; Roberts JA
    Br J Anaesth; 2017 Jun; 118(6):876-882. PubMed ID: 28505360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children.
    Cies JJ; Moore WS; Parker J; Stevens R; Al-Qaqaa Y; Enache A; Chopra A
    J Antimicrob Chemother; 2019 May; 74(5):1342-1347. PubMed ID: 30689931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Cefazolin and Vancomycin in Infants Undergoing Open-Heart Surgery With Cardiopulmonary Bypass.
    Ingrande J; Gutierrez K; Lemmens HJ; Verma A; Nicolau DP; Sutherland CA; Ramamoorthy C
    Anesth Analg; 2019 May; 128(5):935-943. PubMed ID: 30995208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle and plasma concentrations of cefazolin during cardiac surgery in infants.
    Himebauch AS; Nicolson SC; Sisko M; Moorthy G; Fuller S; Gaynor JW; Zuppa AF; Fox E; Kilbaugh TJ
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2634-41. PubMed ID: 25131168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.
    Aalbers M; ter Horst PG; Hospes W; Hijmering ML; Spanjersberg AJ
    Int J Clin Pharm; 2015 Aug; 37(4):592-8. PubMed ID: 25791346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.
    Calic D; Ariano RE; Arora RC; Grocott HP; Lakowski TM; Lillico R; Zelenitsky SA
    J Antimicrob Chemother; 2018 Mar; 73(3):768-771. PubMed ID: 29237016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Cefazolin in Patients With Obesity Undergoing Surgery Requiring Cardiopulmonary Bypass.
    Poltak J; Connors C; Wungwattana M; Nicolau D; Mercuro NJ; Liu J
    J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2942-2947. PubMed ID: 35227575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Dosing Strategy for Cefazolin for Surgery Requiring Cardiopulmonary Bypass.
    Hollis AL; Heil EL; Nicolau DP; Odonkor P; Dowling TC; Thom KA
    Surg Infect (Larchmt); 2015 Dec; 16(6):829-32. PubMed ID: 26291478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Cefazolin Dosing in Women With Body Mass Index >35 kg·m-2 Undergoing Cesarean Delivery: A Pharmacokinetic Study of Plasma and Interstitial Fluid.
    Eley VA; Christensen R; Ryan R; Jackson D; Parker SL; Smith M; van Zundert AA; Wallis SC; Lipman J; Roberts JA
    Anesth Analg; 2020 Jul; 131(1):199-207. PubMed ID: 32250982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.
    Gertler R; Gruber M; Wiesner G; Grassin-Delyle S; Urien S; Tassani-Prell P; Martin K
    Br J Clin Pharmacol; 2018 Sep; 84(9):2020-2028. PubMed ID: 29761538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass-authors' response.
    Zelenitsky SA; Calic D; Ariano RE
    J Antimicrob Chemother; 2018 Sep; 73(9):2588. PubMed ID: 29945163
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot and feasibility study of the plasma and tissue pharmacokinetics of cefazolin in an immature porcine model of pediatric cardiac surgery.
    Kilbaugh TJ; Himebauch AS; Zaoutis T; Jobes D; Greeley WJ; Nicolson SC; Zuppa AF
    Paediatr Anaesth; 2015 Nov; 25(11):1111-9. PubMed ID: 26372607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population pharmacokinetic modelling of total and unbound cefazolin plasma concentrations as a guide for dosing in preterm and term neonates.
    De Cock RF; Smits A; Allegaert K; de Hoon J; Saegeman V; Danhof M; Knibbe CA
    J Antimicrob Chemother; 2014 May; 69(5):1330-8. PubMed ID: 24492261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.
    Ferreira F; Santos S; Nascimento J; Strabelli T; Carmona M
    Eur J Cardiothorac Surg; 2012 Aug; 42(2):300-5. PubMed ID: 22290920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
    Brill MJ; Houwink AP; Schmidt S; Van Dongen EP; Hazebroek EJ; van Ramshorst B; Deneer VH; Mouton JW; Knibbe CA
    J Antimicrob Chemother; 2014 Mar; 69(3):715-23. PubMed ID: 24214905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
    Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.